Lai, Zhihong <br/><br/>
Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example.  [electronic resource] 

 -  RMD open  2016 
 - e000154 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2056-5933 
<br/><br/><label>Standard No.: </label>10.1136/rmdopen-2015-000154  doi